These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37131875)

  • 1. Implementation and evaluation of a dynamic contrast enhanced MR perfusion protocol for glioblastoma using a 0.35T MRI-Linac system.
    Maziero D; Azzam G; de La Fuente M; Stoyanova R; Ford JC; Mellon EA
    ArXiv; 2023 Apr; ():. PubMed ID: 37131875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation and evaluation of a dynamic contrast-enhanced MR perfusion protocol for glioblastoma using a 0.35 T MRI-Linac system.
    Maziero D; Azzam GA; de La Fuente M; Stoyanova R; Ford JC; Mellon EA
    Phys Med; 2024 Mar; 119():103316. PubMed ID: 38340693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid multicontrast brain imaging on a 0.35T MR-linac.
    Nejad-Davarani SP; Zakariaei N; Chen Y; Haacke EM; Hurst NJ; Salim Siddiqui M; Schultz LR; Snyder JM; Walbert T; Glide-Hurst CK
    Med Phys; 2020 Sep; 47(9):4064-4076. PubMed ID: 32434276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of diffusion-weighted MRI and geometric distortion on a 0.35T MR-LINAC at multiple gantry angles.
    Lewis B; Guta A; Mackey S; Gach HM; Mutic S; Green O; Kim T
    J Appl Clin Med Phys; 2021 Feb; 22(2):118-125. PubMed ID: 33450146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of real-time cine MR imaging distortion on 0.35 T MRgRT with concentric cine imaging QA phantom.
    Marasini S; Cole M; Curcuru A; Dyke LM; Gach HM; Flores R; Kim T
    Phys Med Biol; 2024 Mar; 69(6):. PubMed ID: 38408387
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator.
    Kooreman ES; van Houdt PJ; Nowee ME; van Pelt VWJ; Tijssen RHN; Paulson ES; Gurney-Champion OJ; Wang J; Koetsveld F; van Buuren LD; Ter Beek LC; van der Heide UA
    Radiother Oncol; 2019 Apr; 133():156-162. PubMed ID: 30935572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Deep Learning Approach for Automatic Segmentation during Daily MRI-Linac Radiotherapy of Glioblastoma.
    Breto AL; Cullison K; Zacharaki EI; Wallaengen V; Maziero D; Jones K; Valderrama A; de la Fuente MI; Meshman J; Azzam GA; Ford JC; Stoyanova R; Mellon EA
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCE-MRI is more sensitive than IVIM-DWI for assessing anti-angiogenic treatment-induced changes in colorectal liver metastases.
    Rata M; Khan K; Collins DJ; Koh DM; Tunariu N; Bali MA; d'Arcy J; Winfield JM; Picchia S; Valeri N; Chau I; Cunningham D; Fassan M; Leach MO; Orton MR
    Cancer Imaging; 2021 Dec; 21(1):67. PubMed ID: 34924031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging may act as a biomarker for vascular damage in normal appearing brain tissue after radiotherapy in patients with glioblastoma.
    Fahlström M; Fransson S; Blomquist E; Nyholm T; Larsson EM
    Acta Radiol Open; 2018 Nov; 7(11):2058460118808811. PubMed ID: 30542625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C; Castellano A; Conte GM; Cadioli M; Iadanza A; Terreni MR; Franzin A; Bello L; Caulo M; Falini A; Anzalone N
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
    Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
    PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted imaging on an MRI-linear accelerator to identify adversely prognostic tumour regions in glioblastoma during chemoradiation.
    Lawrence LSP; Chan RW; Chen H; Stewart J; Ruschin M; Theriault A; Myrehaug S; Detsky J; Maralani PJ; Tseng CL; Soliman H; Jane Lim-Fat M; Das S; Stanisz GJ; Sahgal A; Lau AZ
    Radiother Oncol; 2023 Nov; 188():109873. PubMed ID: 37640160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of survival and progression in glioblastoma patients using temporal perfusion changes during radiochemotherapy.
    Larsson C; Groote I; Vardal J; Kleppestø M; Odland A; Brandal P; Due-Tønnessen P; Holme SS; Hope TR; Meling TR; Fosse E; Emblem KE; Bjørnerud A
    Magn Reson Imaging; 2020 May; 68():106-112. PubMed ID: 32004711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
    Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
    Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of conventional and machine learning-based tumor auto-segmentation techniques using undersampled dynamic radial bSSFP acquisitions on a 0.35 T hybrid MR-linac system.
    Friedrich F; Hörner-Rieber J; Renkamp CK; Klüter S; Bachert P; Ladd ME; Knowles BR
    Med Phys; 2021 Feb; 48(2):587-596. PubMed ID: 33319394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical experience of MRI
    Kim T; Lewis B; Lotey R; Barberi E; Green O
    J Appl Clin Med Phys; 2021 Jan; 22(1):128-136. PubMed ID: 33336884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of overall survival in patients with newly diagnosed glioblastoma with contrast-enhanced perfusion MRI: Comparison of intraindividually matched T1 - and T2 (*) -based bolus techniques.
    Bonekamp D; Deike K; Wiestler B; Wick W; Bendszus M; Radbruch A; Heiland S
    J Magn Reson Imaging; 2015 Jul; 42(1):87-96. PubMed ID: 25244574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric feasibility of hippocampal avoidance whole brain radiotherapy with an MRI-guided linear accelerator.
    Graham JA; Redler G; Delozier KB; Yu HM; Oliver DE; Rosenberg SA
    J Appl Clin Med Phys; 2022 Jun; 23(6):e13587. PubMed ID: 35344266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric comparison of glioblastoma radiotherapy treatment plans on a low-field MRI-guided linear accelerator compared to conventional C-arm linear accelerator.
    Moats E; Siddiqui MS; Parikh P; Snyder KC
    Med Dosim; 2024 Autumn; 49(3):215-221. PubMed ID: 38233319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study.
    Klaar R; Rabe M; Gaass T; Schneider MJ; Benlala I; Eze C; Corradini S; Belka C; Landry G; Kurz C; Dinkel J
    Radiat Oncol; 2023 Apr; 18(1):58. PubMed ID: 37013541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.